Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.
In 1999 was created Kapor Capital, which is appeared as VC. The main department of described VC is located in the Oakland. The fund was located in North America if to be more exact in United States.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Kapor Capital, startups are often financed by Imagine K12, NewSchools Venture Fund, Cross Culture Ventures. The meaningful sponsors for the fund in investment in the same round are Ulu Ventures, Marc Bell Ventures, Felicis Ventures. In the next rounds fund is usually obtained by True Ventures, GV, Y Combinator.
Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most successful fund investment fields, there are Information Technology, SaaS. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Uber, Omada Health, Thrive Market. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
This organization was formed by Freada Klein-Kapor, Mitch Kapor. Besides them, we counted 5 critical employees of this fund in our database.
The top amount of exits for fund were in 2019. The usual things for fund are deals in the range of 5 - 10 millions dollars. The fund is generally included in 13-24 deals every year. The real fund results show that this VC is 11 percentage points less often commits exit comparing to other companies. The typical startup value when the investment from Kapor Capital is 10-50 millions dollars. Opposing the other organizations, this Kapor Capital works on 11 percentage points less the average amount of lead investments. The top activity for fund was in 2015.
Related Funds
Discover 4 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Daylight | $15M | 18 Nov 2022 | Los Angeles, California, United States | ||
Bridge | $5M | 28 Sep 2022 | Chicago, Illinois, United States | ||
Ethic | $50M | 14 Sep 2022 | New York, New York, United States | ||
Joonko | $25M | 13 Sep 2022 | Birmingham, Alabama, United States | ||
Daivergent | $3M | 01 Aug 2022 | New York, New York, United States | ||
Welcome | 22 Jun 2022 | Denver, Colorado, United States | |||
Kinly | $15M | 13 Jun 2022 | - | ||
Cayaba Care | $12M | 19 May 2022 | Philadelphia, Pennsylvania, United States | ||
Promise | $25M | 24 Feb 2022 | Oakland, California, United States |
– TomoCredit, a fintech company offering a credit card focused on building a credit history for first-time borrowers, announced a $10 million Series A funding round led by Kapor Capital and KB Investment, a subsidiary of South Korea’s leading consumer bank.
– The company also appointed Ash Gupta, former CRO at American Express, to the board.
– emocha Health, a digital health company which radically improves medication adherence amongst patients with chronic and infectious diseases, today announced the closing of a $6.2 million Series A funding round.
– The financing was led by Claritas Health Ventures and includes participation from Healthworx, the innovation and investment arm of CareFirst BlueCross BlueShield, Kapor Capital, and PTX Capital.
– emocha is the first company to comprehensively digitize the CDC-endorsed practice of Directly Observed Therapy — the gold standard for medication adherence, using a combination of two-way asynchronous video technology and human engagement powered by artificial intelligence.
– emocha is tackling one of the biggest unsolved challenges in healthcare – medication non-adherence, which results in $300 billion a year in preventable hospitalizations.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 
Get matched with relevant funds
